Levy, J.: "Les spasmolytiques", J. Physiol., Paris, 40: 23-61, (1948) and many others.
3.
Herschel, J.G. : De werking van B.S. 572 bij het intermitterend hinken. Geneesk. Gids, 29: 26, 1951.
4.
Van Wijk, Theo W.: The treatment of peripheral vascular diseases with cyclospasmol. Angiology, vol. 4, no. 2, April, 1953.
5.
Funcke, A.B.H. : Pharmacological investigation on the spasmolytic activity of a series of mandelic acid esters, especially the ester of 3.5.5-trimethylcyclohexanol (cyclospasmol), Thesis, Vrije Universiteit, Amsterdam, 1952.
6.
Ruberti, U., and Magliulo, V.: Experimental and clinical observations on peripheral vaso-motor action by cyclospasmol. Rassegna Italiana di Chirurgia eMedicina6: 11, 1957.
7.
Shaftel, H.E. , Samuels, S., and Padernacht , Elias.: A clinical study of a musculotropic vasodilating compound, Angiology12, Sept. 423, 1961.
8.
Popkin, Roy, Jr.: Medical treatment of peripheral vascular diseases, Angiology, 12: Sept.427,1961.
9.
Mahl, Murray M.: Vasodilators and the use of cyclospasmol in peripheral vascular disease, Angiology, 12: Sept. 432, 1961.
10.
Leslie, R.E. : Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances. Texas J. Med., 56: 352, 1960.
11.
Nieveen, J. , Rodbard, J.A., and Van Wijk , T.W.: Diagnosis and therapy of peripheral vascular diseases; experiences with cyclospasmol (mandelic acid derivative). Med. Lijdschrift voor Geneesk., 98: 205, 1954.
12.
Gillespy, R.O. : An evaluation of the various peripheral dilators used in the treatment of intermittent claudication. Brit. J. Clin. Practice, 13: 608, 1959.
13.
Sherber, Daniel A.: The rational use of vasodilating agents in chronic peripheral arterial and arteriolar vascular disorders, Angiology, 14: Jan. 55, 1963.